Peer to Peer

What Is the Nocebo Effect?

In this edition of the “Peer to Peer” audiocast series, Dr. Vincent DeLeo speaks with Dr. Philip D. Shenefelt about the nocebo effect and how it can affect dermatologists’ interactions with their patients. Dr. Shenefelt explains that the nocebo effect, which is the converse of the more widely known placebo effect, leads to adverse treatment outcomes that may occur based on negative beliefs of both patients and physicians. He offers tips for physicians regarding how to speak to patients without encouraging negative expectations or beliefs that could possibly impact treatment.

Questions for Dr. Philip Shenefelt on the nocebo effect? Contact the Editorial Office and we'll post the answer here.


 

Recommended Reading

British Society of Rheumatology issues first U.K. lupus guideline
MDedge Dermatology
Chromoblastomycosis Infection From a House Plant
MDedge Dermatology
MACRA in a nutshell
MDedge Dermatology
Adverse effects low in long-term crisaborole eczema study
MDedge Dermatology
Levofloxacin-Induced Purpura Annularis Telangiectodes of Majocchi
MDedge Dermatology
Make The Diagnosis - November 2017
MDedge Dermatology
Mental health risks higher in sexual minorities with acne
MDedge Dermatology
A Peek at Our October 2017 Issue
MDedge Dermatology
“I’m sorry, doctor, I’m afraid I can’t do that”
MDedge Dermatology
T-VEC improves melanoma response without toxicity increase
MDedge Dermatology

Related Articles